在冷却气球移除后,对左前庭内壁血瘤进行保守的治疗
Taku Shimojo1, Naoaki Onishi2, Ren Kimura2
1Department of Cardiology, Japanese Red Cross Osaka Hospital, Osaka, Japan; Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan.
JACC. Case reports
|December 4, 2025
概括
左心室室内血瘤 (LAIH) 是心房手术的罕见并发症,在稳定的患者中可以有效地进行保守的治疗. 早期检测和监测导致了没有手术的成功解决方案.
科学领域:
- 心脏病学 心脏病学
- 医学案例报告 病例报告
背景情况:
- 左心室内静脉血瘤 (LAIH) 是左心室手术后的一种非常罕见的并发症.
- 心房移除手术带有固有的风险,包括像LAIH这样的罕见并发症.
研究的目的:
- 报告一个LAIH病例,该病例是由于心房动引起的冷却气球移除后发生的.
- 突出在血液动力学上稳定的患者中成功进行LAIH的保守管理.
主要方法:
- 一名50岁的男性患者接受了冷气球移除,以治疗心脏动.
- 在手术后立即通过心内心声谱诊断出左心房内腔血瘤.
- 由于血液动力学稳定性,启动了包括床上休息和密切监测在内的保守管理.
主要成果:
- 在整个治疗期间,患者在血液动力学上保持稳定.
- 在LAIH,病情逐渐回落.
- 患者在术后第13天出院,没有出现次要并发症.
结论:
- 保守管理是诊断为LAIH的血液动力稳定患者的可行和有效策略.
- 早期识别和迅速干预对于LAIH的成功解决至关重要.
更多相关视频
相关概念视频
Mitral Stenosis III: Medical Management
223
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
223
Mitral Regurgitation III: Medical Management
257
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
257
Pericarditis III: Medical Management
286
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
286
Cardiomyopathy V: Interprofessional Care
314
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
314
Cardiomyopathy III: Hypertrophic Cardiomyopathy
374
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374
Aortic Regurgitation III: Medical Management
375
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
375


